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ThemilkywhitelatexofplantCalotropisproceraproducesinﬂammationoftheskinandmucousmembranesonaccidentalexposure.
It produces edema on local administration due to the release of histamine and prostaglandins and is associated with hyperalgesia.
In the present study we have evaluated the antiedematous and analgesic activity of antiinﬂammatory drugs against inﬂammatory
response induced by dried latex (DL) of Cp r o c e r ain rat paw edema model. An aqueous extract of DL of Cp r o c e r awas injected
into the subplantar surface of the rat paw and the paw volume was measured by a plethysmometer at 0, 1, 2, 6, 12, and 24hours.
Concomitantly the hyperalgesic response was also evaluated by motility test, stair climbing ability test, dorsal ﬂexion pain test,
compression test, and observing the grooming behavior. The inhibitory eﬀect of diclofenac and rofecoxib on edema formation and
hyperalgesic response was compared with cyproheptadine (CPH). DL-induced edema formation was maximum at 2hours that was
associated with decreased pain threshold, functional impairment, and grooming. Treatment with antiinﬂammatory drugs and CPH
signiﬁcantly attenuated the edematous response and grooming, increased the pain threshold, and improved functional parameters.
Both antiinﬂammatory and antiserotonergic drugs signiﬁcantly inhibited the hyperalgesia associated with DL-induced paw edema.
Rofecoxib was found to be superior than diclofenac and was as eﬀective as CPH in ameliorating the hyperalgesia. However, it was
found to be less eﬀective than CPH in attenuating edema formation.
INTRODUCTION
Calotropis procera (Ait) R Br, a plant of family Ascle-
piadaceae, is well known for its medicinal as well as toxic
properties [1, 2]. The plant produces milky white latex
that exhibits pleiotropic eﬀects in various animal mod-
els [3]. On oral administration, the latex produces potent
antiinﬂammatory, analgesic, and weak antipyretic eﬀects,
while on local administration it induces intense inﬂam-
matory response [4, 5, 6, 7]. Even the accidental expo-
suretothelatexproducescontactdermatitis,keratitis,and
toxic iridocyclitis [8, 9, 10]. The acute inﬂammation in-
duced by latex involves edema formation and cellular in-
ﬁltration that has been attributed to the presence of his-
tamine in the latex and the release of mast cell histamine
[7, 11]. Besides, the latex has also been shown to induce
prostaglandin (PG) synthesis through the induction of
cyclooxygenase-2 (COX-2) [12]. Both histamine and PGs
are the key mediators in an inﬂammatory response and
play a signiﬁcant role in inﬂammatory hyperalgesia along
with various other mediators [13, 14]. These inﬂamma-
tory mediators activate local pain receptors (ie, nocicep-
tors) and nerve terminals that produce hypersensitivity
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in the area of injury as observed in various inﬂammatory
conditions [15, 16].
Studies carried out in various acute and chronic mod-
els of inﬂammation demonstrate that cyproheptadine
(CPH), celecoxib, and phenylbutazone signiﬁcantly in-
hibit inﬂammatory response elicited by the latex of C
procera, h o w e v e r ,C P Hi sm o s te ﬀective in this regard
[11]. Besides inhibiting inﬂammation, these drugs are
also known to produce analgesic eﬀect [17, 18, 19]. In
the present study, we have evaluated the eﬀect of antiin-
ﬂammatory drugs, rofecoxib and diclofenac, against in-
ﬂammatory hyperalgesia induced by latex of Cp r o c e r ain
paw edema model and compared it with CPH. A bat-
tery of tests were performed to evaluate the eﬀect of
these drugs on edema formation, motility, stair climb-
ing ability (SCA), pain associated with dorsal ﬂexion,
compression,andbehavioralparameter,thatis,grooming
[20, 21].
MATERIALS AND METHODS
Plantmaterialanddrugs
The latex of Cp r o c e r awas collected from the aerial
parts of the plant growing in the wild and was dried un-
der shade (DL). It was then triturated in normal saline
(NS) and centrifuged to obtain a clear solution. The
plant was identiﬁed by the Raw Materials, Herbarium,
and Museum Division, National Institute of Science and2005:4 (2005) Cp r o c e r aLatex-Induced Inﬂammatory Hyperalgesia 217
Communication,NewDelhi,whereavoucherspecimenis
preserved (Voucher no PID 1739). The drugs used in this
study were obtained from Merind India Ltd (Mumbai,
Maharashtra, India) (Cyproheptadine) and Arbro Phar-
maceuticals (New Delhi, India) (Diclofenac and Rofe-
coxib).
Animals
The study was carried out on male Wistar rats weigh-
ing 150–180g. They were kept at ambient temperature
and had free access to water and diet. All experimental
procedures described were carried out in accordance with
the guidelines of Institutional Animal Ethics Committee.
InductionofpawedemabyDL
Edema was induced in the right hind paw of rats by
injecting 0.1mL of 1% solution of DL and paw volume
was measured upto a ﬁxed mark on the lateral malleo-
l u sa t0 ,1 ,2 ,6 ,1 2 ,a n d2 4h o u r su s i n gap l e t h y s m o m e -
ter. Edema volume was calculated at each time interval as
the diﬀerence from paw volume at 0hour. Cyprohepta-
dine (10mg/kg; CPH10), diclofenac (10 and 100mg/kg;
Diclo10 and Diclo100) and rofecoxib (15 and 100mg/kg;
Rofe15 and Rofe100) were administered orally as suspen-
sion with 5% gum acacia in NS 1hour before injecting
DL. The eﬀect of antiinﬂammatory drugs at each time in-
terval was evaluated on the stair climbing ability, motility,
grooming behavior, and pain produced by dorsal ﬂexion
and compression.
Stairclimbingabilitytest
The overnight fasted animals were trained for one
week to climb a staircase with steps at 5, 10, and 15cm
having water at the second and food at the third step
[20, 21]. The climbing ability of the rats in the above
groups was scored 0 if the rats did not climb; 1, if the rats
climbedontostep1;2,iftheratsclimbeduptostep2;and
3, if the rat could climb all the three steps.
Motilitytest
The motility pattern of the rats was observed for a pe-
riod of 5minutes and scored 0, if the rat avoided touching
the inﬂamed paw to the ﬂoor while walking; 1, if the rat
walked with little diﬃculty, but the toe touched the ﬂoor;
and 2, if the rat walked easily [20, 21].
Dorsalﬂexionpaintest
The ankle joint was ﬂexed dorsally until the toe
touched the anterior part of the leg. The test was per-
formed ﬁve times with an intertest interval of 5 seconds
and the pain was scored 0, if there was no squeaking and
no leg withdrawal; 1, if there was either squeaking or leg
withdrawal; and 2, if both squeaking and leg withdrawal
were present [20].
Compressiontest
The thickness of inﬂamed paw was measured by the
micrometer screw gauze and the paw was compressed by
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Figure 1. Time course for DL-induced edema formation and
extent of compression required to elicit pain in rat paw. Aque-
ous solution of DL of Cp r o c e r a(0.1mL of 1% solution) and NS
(0.1mL) were injected into the subplantar surface of the rat paw
and edema volume and compression were measured at 1, 2, 6,
12, and 24hours (n = 6). Bars indicate edema volume and lines
indicate compression to elicit pain.
rotating the screw till pain was elicited as indicated by
squeaking or leg withdrawal. The distance moved by the
screw gauze was recorded.
Groomingbehavior
The rats were observed for 10 minutes and the num-
ber of grooming was recorded [20].
Statisticalanalysis
The values for edema volume, compression, and
grooming are expressed as mean ± standard error of the
mean of six observations and student’s t test was used
to compare the groups. The stair climbing ability test,
motility, and pain following dorsal ﬂexion are expressed
asmedianscoresandKruscal-Wallistestwasusedtocom-
pare the groups. The statistical analysis was carried out by
the version 10 of the SPSS programme and the values of
P<. 05 was considered as statistically signiﬁcant.
RESULTS
Subplantar injection of aqueous solution of DL of
Cp r o c e r ap r o d u c e da ne d e m a t o u sr e s p o n s ew i t hp e a k
edema occurring at 2hours whereas NS produced a
marginal increase in paw volume at ﬁrst hour that was
equivalent to the volume of NS injected (Figure 1). Figure
1 also shows that the pain threshold in DL-treated paw
was much lower as compared to NS-treated paw and the
paw could be compressed only by 0.03 ± 0.01mm against
0.18 ± 0.02mm in NS control group. As the inﬂamma-
tion declined, the extent of compression required to elicit
pain increased. We further studied the antiedematous ef-
fectofvariousdrugsinpawedemamodelat2hours.Both
diclofenac and rofecoxib produced a dose-dependent ef-
fect and the edema volume was 0.22 ± 0.002mL and218 R. Sehgal and V. L. Kumar 2005:4 (2005)
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Figure 2. Antiinﬂammatory eﬀect of various drugs on DL-
induced paw edema. Edema was induced by injecting 0.1mL
of 1% solution of DL into subplantar surface of right hind
paw. The drugs were administered orally 1hour before inject-
ing DL. Edema volume was measured at 2hours (n = 6). CPH
10-cyproheptadine 10mg/kg; Diclo 10-diclofenac 10mg/kg; Di-
clo 100-diclofenac 100mg/kg; Rofe 15-rofecoxib 15mg/kg; Rofe
100-rofecoxib 100mg/kg; ∗P<. 01 and ∗∗P<. 05 versus DL
control.
0.16 ± 0.01mL in Diclo 100 and Rofe 100 groups against
0.47 ± 0.01mL in DL control. CPH was most eﬀective in
thisregardandtheedemavolumeinCPH-treatedratswas
0.09 ±0.03mL (Figure 2).
As inﬂammation is usually associated with hyperal-
gesia, the eﬀect of various drugs was also evaluated on
the pain threshold. Both diclofenac and rofecoxib pro-
duced a dose-dependent eﬀectandthe pawcouldbe com-
pressedupto0.09±0.01mmand0.12±0.01mmasagainst
0.03 ± 0.01mm in DL control. The eﬀect of CPH 10
was similar to that of Diclo100 (Table 1). The inﬂamma-
tory pain induced by DL was found to be associated with
grooming(11.4±0.75)whileNScontrolgroupdidnotex-
hibit any grooming. Treatment of rats with diclofenac and
rofecoxib signiﬁcantly decreased the number of groom-
ing activity to 4.50 ± 0.50 and 4.00 ± 0.41 while it was
5.80 ±0.85 in CPH-treated group (Table 1).
The eﬀect of these drugs was further evaluated on the
pain produced by the ﬂexion of the inﬂamed paw. The
time course study was carried out and a maximum me-
dian score of 9.5 was obtained at 1hour following DL in-
jection and the pain persisted upto 24hours. CPH was
found to be most eﬀective in decreasing the pain response
as compared to diclofenac and rofecoxib and a score of
4, 6, and 5.5, respectively, was obtained after 1hour (P<
.01) (Figure 3).
We further tested the ability of the animals to move
and to climb staircase at the time of peak inﬂammation.
TheanimalsintheDLcontrolgroupexhibitedascoreof 0
with respect to motility and stair climbing ability whereas
the animals in the NS control group exhibited a maxi-
mum motility score of 2 and stair climbing ability score
of 3. Both diclofenac and rofecoxib improved the motil-
ity and stair climbing ability in a dose-dependent manner
and rats in Rofe100 group could climb all the three steps
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Figure 3. Antihyperalgesic eﬀect of various drugs on DL-
induced inﬂammatory hyperalgesia. Edema was induced by in-
jecting 0.1mL of 1% solution of DL into subplantar surface of
right hind paw. The drugs were administered orally 1hour be-
fore injecting DL. Dorsal ﬂexion pain score was recorded at 1,
2, 6, 12, and 24hours (n = 6). The data is illustrated as box
plots where bold line represents median values, boxes represent
interquartile ranges (25th and 75th percentiles), and whiskers
represent extreme values.
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Figure 4. Eﬀect of various drugs on DL-induced motility im-
pairment and staircase climbing ability (SCA). Edema was in-
duced by injecting 0.1mL of 1% solution of DL into subplantar
surface of right hind paw. The drugs were administered orally
1hour before injecting DL. Motility and staircase climbing abil-
itywereobservedat2hours(n = 6). ∗P<. 01versusDLcontrol.
andtheirmotilityscorewas2whileratsinDiclo100group
could climb up to step 2 even though they did not have
any diﬃculty in motility. CPH at a dose of 10mg/kg was
as eﬀective as 100mg/kg dose of rofecoxib (Figure 4).
DISCUSSION
Inthepresentstudywehaveevaluatedtheeﬀectofan-
tiinﬂammatory drugs on the inﬂammatory hyperalgesia
induced by latex of Cp r o c e r a , when injected into the2005:4 (2005) Cp r o c e r aLatex-Induced Inﬂammatory Hyperalgesia 219
Table 1. Eﬀect of various drugs on DL-induced inﬂammatory hyperalgesia and associated behavioral changes. Edema was induced
by injecting 0.1mL of 1% solution of DL into subplantar surface of right hind paw. The drugs were administered orally 1hour before
injecting DL. Extent of compression and number of groomings were recorded at 2hours. The values given are mean ± standard error
of the mean (n = 6).
Treatment groups Compression (mm) Groomings (number)
NS control 0.18 ±0.02 —–
DL control 0.03 ±0.01 11.40 ±0.75
Cyproheptadine (10mg/kg) 0.09 ±0.01∗ 5.82 ±0.85∗
Diclofenac (10mg/kg) 0.07 ±0.01∗ 7.50 ±0.65∗
Diclofenac (100mg/kg) 0.09 ±0.01∗ 4.50 ±0.50∗
Rofecoxib (15mg/kg) 0.07 ±0.01∗ 7.50 ±0.29∗
Rofecoxib (100mg/kg) 0.12 ±0.00∗ 4.00 ±0.41∗
∗P<. 05 versus DL control.
paw. Subplantar injection of aqueous solution of DL pro-
duced intense inﬂammatory response with a peak eﬀect
occurring at 2hours. This was associated with hyperal-
gesia that was maximum between 1–2hours and a slight
compression of the inﬂamed paw caused leg withdrawal
and squeaking. Subsequently as the inﬂammation sub-
sided, the extent of compression required to elicit pain
also increased. As reported earlier, the inﬂammatory re-
sponse induced by DL is brought about by the histamine
present in it and also by the release of endogenous his-
tamine from mast cells [11].
Edema and pain are characteristic signs of an inﬂam-
matory response where the role of prostaglandins and
histamine is well established [13]. Prostaglandins are en-
dogenous mediators of inﬂammation and are generated
from arachidonic acid by the action of cyclooxygenase
(COX) that exists in two isoforms, COX-1 and COX-2.
COX-1 is constitutive whereas COX-2 is the cytokine in-
ducible form of the enzyme. We have evaluated the ef-
fect of diclofenac, a nonselective COX inhibitor, and ro-
fecoxib, a COX-2 selective inhibitor, on inﬂammatory hy-
peralgesia induced by DL and compared it with CPH
that has been shown to eﬀectively inhibit DL-induced in-
ﬂammation[11].Although,diclofenacandrofecoxibpro-
duced a dose-dependent decrease in edema formation,
they were not as eﬀective as CPH. CPH inhibits the pre-
formed histamine and serotonin that are released early
in an inﬂammatory response while PG are synthesized
late and their maximum levels are attained between 3–
12hours after induction of inﬂammation [13, 22]. CPH
produced a signiﬁcant decrease in inﬂammatory hyperal-
gesia as revealed by compression test, dorsal ﬂexion pain
test and grooming activity. The analgesic eﬀect of CPH
could be mainly due to its ability to inhibit the action of
histamine, serotonin, and bradykinin, all of which are key
mediators of inﬂammatory hyperalgesia [13, 23]. Both
diclofenac and rofecoxib were also eﬀective as analgesics
even though their antiedematous eﬀect was less as com-
pared to CPH. Further, rofecoxib was found to be slightly
more eﬀective than diclofenac. The greater eﬃcacy of
rofecoxib as compared to diclofenac in relieving acute
pain has also been reported by Desjardins et al [24]. The
hypoalgesic eﬀect of COX inhibitors has been attributed
to the selective inhibition of COX-2 and is brought about
at doses that may not cause reduction in edema volume
[25]. It may also be due to selective inhibition of COX-2
in the dorsal horn neurons of the spinal cord that con-
tributes to the nociceptive processing [26]. The eﬃcacy of
antiinﬂammatory drugs against DL-induced inﬂamma-
toryhyperalgesiawasfurthersubstantiatedbytheirability
to improve motility and stair climbing ability.
Thus, our study indicates that edema formation in-
duced by DL could be eﬀectively inhibited by CPH
whereas the associated inﬂammatory hyperalgesia is in-
hibited equally by both CPH and rofecoxib.
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